Daniel Mccoy is a Vice President - Preclinical Programs (Gene Therapy) at Avista Therapeutics. He possess expertise in molecular biology, molecular cloning, western blotting, neuroscience, assay development and 22 more skills. Colleagues describe him as "Dan worked as an intern in my lab before he started graduate school. His work was meticulous and his enthusiasm energizing. He approached his project with keen intelligence and obvious commitment. Dan has great people skills, and quickly became known as a colleague who could be relied upon to contribute where ever and when ever the opportunity arose.", "Dan was hired within our department as an intern and contractor, reporting to a colleague of mine. He assimilated very quickly and performed a variety of assays to support biomarker discovery in inflammation projects. He proved to be a very productive scientist whose data was reliable and trusted. He quickly became a valued member of the group during his tenure and worked well with everyone. I recommend Dan unconditionally.", and "I hired Daniel McCoy in 2008 to support our efforts in the development of ACAM529, a vaccine against genital herpes. Not only did Dan display a great deal of professionalism and competence in his work, but he also was a pleasure to work with at all times. Dan carried out successfully a number of virology and molecular biology experiments involving determination of viral titers by plaque assay and assessment of genetic stability of complementing eukaryotic cell lines by Southern blotting of DNA samples he isolated. He demonstrated a clear ability to carry out complex procedures independently as well as significant problem-solving skills. I would enthusiastically recommend Daniel McCoy to anyone interested in hiring him and wish him the best as he progresses in his career."